Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

Control of Cleaning Tools and Accessories in GMP Areas

Posted on November 25, 2025November 24, 2025 By digi


Control of Cleaning Tools and Accessories in GMP Areas: Step-by-Step Tutorial

Effective Control of Cleaning Tools and Accessories in GMP Areas: A Step-by-Step Guide

Ensuring the control of cleaning tools and accessories in GMP areas is an essential aspect of pharmaceutical manufacturing. The proper management of items such as mops, wipes, brushes, and other cleaning aids directly impacts product quality, contamination control, and regulatory compliance. As pharmaceutical professionals working within the US, UK, and EU regulatory frameworks, understanding and implementing stringent controls aligned with FDA, EMA, MHRA, PIC/S, and WHO GMP expectations is paramount.

This comprehensive tutorial provides a detailed step-by-step approach to effectively controlling cleaning tools and accessories used in GMP environments, addressing segregation, labelling, handling, storage, and monitoring processes. It is aimed at manufacturing personnel, quality assurance, quality control, validation, and regulatory affairs teams tasked with contamination control and facility hygiene management.

Step 1: Define the Scope and Classification of Cleaning Tools and Accessories

The first step in controlling cleaning tools and accessories in GMP areas is to clearly define which items fall under control and establish their classification according to risk and usage. This foundational classification supports subsequent procedures for segregation, handling, and labelling.

  • Identify Cleaning Tools: Include mops, mop heads, wipes (both pre-impregnated and dry), brushes, squeegees, dusters, buckets, and gloves used exclusively for cleaning GMP areas.
  • Assess Risk Based on Application: Separate tools used in sterile areas, non-sterile manufacturing, and utility or ancillary areas. Tools for aseptic processing areas require the highest control level due to contamination risks.
  • Define Dedicated vs. General Use: Decide if tools are to be dedicated to specific departments, rooms, or product lines. For example, some facilities require mops dedicated to highly potent or sterile areas only.
  • Classification Matrix: Establish a clear matrix that categorizes tools by material (e.g., microfiber vs. cotton), usage frequency, cleaning solutions employed, and area of application.

By establishing this classification, pharmaceutical manufacturers comply with regulatory expectations regarding contamination control and cross-contamination prevention. For example, the EU GMP guidelines emphasize appropriate equipment segregation in section 4.1 of Volume 4 to prevent cross-contamination.

Also Read:  How to Segregate Cleaning Tools by Area and Product Risk

Step 2: Develop Segregation and Storage Procedures for Cleaning Tools

One critical control measure in the control of cleaning tools and accessories in GMP areas is the establishment of robust segregation and storage procedures to avoid contamination and mix-ups.

  • Physical Segregation: Store cleaning tools for different zones separately (e.g., sterile vs. non-sterile). Use dedicated racks or cupboards clearly marked and restricted to appropriate personnel.
  • Colour Coding: Implement a colour-coding system for tools such as mop handles and heads, buckets, and wipes to visually distinguish their intended use zones. For example, red for high-risk sterile areas, blue for non-sterile areas.
  • Designated Storage Areas: Ensure storage complies with GMP layout principles, in clean, dry, and ventilated areas away from product storage and manufacturing lines.
  • Tool Cleanliness and Dryness Assurance: After use and cleaning/disinfection, tools should be dried appropriately before storage as moisture can promote microbial growth. Storage racks should allow air circulation.
  • Access Control: Limit access to cleaning tool storage to authorised and trained personnel only. Maintain a log or electronic record of tool issuance and return to track utilisation and prevent loss or misuse.

Proper segregation and storage prevent cross-contamination and maintain GMP compliance by eliminating inadvertent transfer of contaminants. In line with FDA 21 CFR Part 211 requirements, maintaining the integrity of cleaning tools is part of the broader equipment control program to assure product quality.

Step 3: Implement Labelling and Identification Systems

Consistent and clear labelling is critical in ensuring proper control of cleaning tools and accessories in GMP areas. Labelling prevents confusion, guarantees proper usage, and facilitates traceability during audits and inspections.

  • Label Contents: Each cleaning tool should bear a label indicating:
    • Area or department of use (e.g., sterile filling, packaging)
    • Color coding if applicable
    • Cleaning or disinfection status (e.g., “clean,” “dirty”)
    • Date of last cleaning or replacement
  • Label Durability: Use easily legible, water-resistant, and chemical-resistant labels or tags suitable for exposure to cleaning agents.
  • Electronic or Manual Tracking: Consider using barcodes or QR codes linking to maintenance or cleaning records, integrating with the facility’s computerized maintenance management system (CMMS) or quality management system (QMS).
  • Label Placement: Labels should be placed prominently on tools, such as the handle of mops or the packaging of wipes, without interfering with their function or cleanliness.
  • Periodic Verification: Auditors and QA personnel should regularly verify label accuracy and condition during routine inspections.
Also Read:  Cleaning Tool Lifecycle: Use, Cleaning, Replacement and Documentation

Using effective labelling and identification systems aligns with the principles in PIC/S GMP Guide, which emphasizes traceability and control of equipment and materials involved in manufacturing processes. This ensures compliance with regulatory expectations and facilitates root cause investigations during deviations or contamination events.

Step 4: Establish Cleaning, Inspection, and Maintenance Programs for Tools

To maintain the integrity of cleaning tools and prevent them from becoming contamination sources, it is essential to establish detailed cleaning, inspection, and maintenance programs.

  • Scheduled Cleaning Procedures: Define cleaning and sanitizing methods for each type of tool, specifying:
    • Cleaning agents compatible with tool materials and effective against anticipated contaminants
    • Cleaning frequency (e.g., daily mop head replacement, weekly deep cleaning)
    • Validated cleaning processes where applicable, to demonstrate effective microbial load reduction
  • Visual and Functionality Inspection: Train personnel to check tools for wear and damage before and after use to detect:
    • Degradation of mop heads or wipes (fraying, staining)
    • Bacterial or fungal growth evidence
    • Integrity of handles, buckets, or dispensers
  • Tool Retirement and Replacement: Define criteria and timelines for retiring tools that no longer meet specifications, such as discoloration, unusable condition, or failure to clean properly.
  • Documentation and Record-Keeping: Maintain records of cleaning activities, inspections, retirements, and replacements, supporting audit trails and process validation.
  • Training and Awareness: Continuously train personnel on correct tool cleaning methods and the importance of compliance to preserve GMP standards.

Ensuring these programs are robust supports contamination control and complies with ICH Q7 and WHO GMP guidelines, which stress equipment and material cleanliness in pharmaceutical manufacturing environments.

Step 5: Control Distribution and Usage of Cleaning Tools During Operations

Even with proper cleaning, segregation, and labelling, operational controls must be implemented to maintain the ongoing control of cleaning tools and accessories in GMP areas.

  • Issuance Procedures: Require authorization for issuing tools from storage, linked with sign-out logs or electronic tracking, to prevent unauthorized removal or cross-area movement.
  • Area-Specific Allocation: Tools issued must correspond strictly to their labelled and designated GMP area, avoiding cross-contamination risks.
  • Single-Use vs. Reusable Items: Define whether wipes or mop heads are disposable after single use or cleaned and reused. For single-use items, establish safe disposal methods.
  • Handling Instructions: Provide clear instructions to personnel on handling cleaning tools to preserve cleanliness, including glove requirements, handling post-cleaning, and minimizing environmental exposure.
  • Contamination Incident Procedures: Create immediate corrective measures if tools are suspected to be contaminated or involved in deviations, including quarantine, investigation, and root cause analysis.
Also Read:  Case Studies: Failures in Uniformity of Dosage Units and CAPA

Close operational control over cleaning tools ensures conformance with GMP requirements and minimizes contamination opportunities. These steps are consistent with FDA 21 CFR Part 211 Subpart D expectations for maintaining clean and controlled manufacturing environments.

Step 6: Conduct Ongoing Monitoring, Auditing, and Continuous Improvement

Long-term assurance of cleaning tool control is achieved by integrating monitoring, audit, and continuous improvement practices into the facility’s quality systems.

  • Internal Audits: Perform regular audits of cleaning tool storage, labelling, cleaning records, and usage practices to verify compliance with established procedures.
  • Environmental Monitoring: Correlate environmental monitoring data (e.g., surface microbiological testing) with cleaning tool control practices to detect contamination trends or lapses.
  • Trend Analysis and Corrective Actions: Analyze non-conformances or discrepancies relating to cleaning tools and implement corrective and preventive actions (CAPA).
  • Management Review: Include cleaning tool control performance in management review meetings to secure resource allocation and policy updates where necessary.
  • Continuous Training Updates: Adapt training programs according to audit findings, changes in regulations, or improvements in cleaning technologies.

These continuous monitoring and quality assurance activities support compliance with EU GMP Annex 15 and ICH Q10 principles concerning pharmaceutical quality systems and process improvement. Establishing a culture of vigilance and accountability around cleaning tools is key to maintaining GMP standards across US, UK, and EU facilities.

Summary and Best Practices

Controlling cleaning tools and accessories in GMP areas is a complex but critical aspect of contamination control within pharmaceutical manufacturing. To summarize best practices:

  • Classify and risk-assess all cleaning tools by area and material.
  • Establish clear segregation and storage systems with colour coding and access control.
  • Implement robust labelling and identification methods for traceability.
  • Define validated cleaning, inspection, and preventative maintenance programs.
  • Exercise strict operational controls during tool issuance and usage.
  • Commit to ongoing monitoring, auditing, and continuous improvement procedures.

This structured, stepwise implementation ensures compliance with regulatory expectations from FDA, EMA, MHRA, PIC/S, and WHO authorities while reducing contamination risks and enhancing product safety and quality. Pharmaceutical professionals responsible for manufacturing, QA, QC, validation, and regulatory functions should integrate these controls into their GMP systems to maintain inspection readiness and support sustainable manufacturing excellence.

Cleaning Tools Tags:cleaning tools, mops, pharmagmp, segregation, wipes

Post navigation

Previous Post: Typical Audit Findings Related to Granulator and Blender Cleaning
Next Post: Inspection Expectations for Dedicated Equipment Documentation

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme